Recombinant Clostridium Strain Engineering for Butanol Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing butanol using Clostridium sp. strains face low yield and productivity issues, along with difficulties in separating butanol from byproducts like acetone and organic acids, leading to increased production costs.
Innovation Solution
Recombinant microorganisms are engineered by deleting genes involved in acetate and butyrate production pathways, such as eutD, buk, and ctfB, and amplifying aldehyde/alcohol dehydrogenase to enhance butanol production and selectivity, resulting in strains like Clostridium acetobutylicum ATCC 824 ΔeutD Δbuk ΔbukII ΔctfB with improved butanol concentration and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If wild-type Clostridium sp. strains are used for butanol production, then the fermentation process is simple, but the butanol yield and productivity are low
Solution Approach 1:
The patent extracts and removes specific genes (pta, ackA, buk) from the Clostridium sp. genome that are responsible for producing unwanted byproducts (acetate and butyrate). By deleting these genes, the metabolic pathway is simplified to favor butanol production, directly increasing butanol yield and productivity while reducing complexity of the overall metabolic network.
Solution Approach 2:
The patent changes the metabolic parameters of Clostridium sp. by modifying gene expression levels and enzyme activities. Specific genes are deleted to alter flux distribution in the metabolic network, redirecting carbon flow toward butanol production. This parameter change transforms the strain from low-productivity wild-type to high-productivity recombinant strain.
2Productivity
If Clostridium sp. strains are used for butanol production, then butanol is produced as a metabolite, but separation from byproducts like acetone and organic acids is difficult
Solution Approach 1:
The patent extracts and eliminates the biochemical pathways responsible for harmful byproduct formation by deleting specific genes. The pta and ackA gene deletions remove the acetate production pathway, while buk gene deletion removes the butyrate production pathway. This extraction of harmful metabolic routes increases butanol concentration and eliminates separation difficulties.
Solution Approach 2:
The patent converts the harmful effect of competing metabolic pathways into a benefit by selectively eliminating them. The deleted genes (pta, ackA, buk) that originally caused byproduct formation and reduced butanol yield are removed, transforming the metabolic network to favor butanol production. This converts the harmful competition for substrates into beneficial directed flux toward butanol.
3Manufacturing precision
If gene deletion is performed to reduce byproduct formation, then butanol selectivity increases, but the complexity of strain engineering increases
Solution Approach 1:
The patent segments the complex metabolic engineering task into discrete, manageable gene deletion steps. Rather than attempting complex multi-gene modifications simultaneously, the approach divides the engineering into sequential deletions of specific genes (pta, ackA, buk), each targeting a specific byproduct pathway. This segmentation makes the complex engineering process more controllable and precise.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered strains significantly increase butanol concentration and yield, reducing the production of organic acids and byproducts, thereby enhancing the efficiency and cost-effectiveness of butanol production.
Implementation Method 1
Clostridium sp. strains which produce solvents such as butanol as metabolites
Implementation Method 2
the metabolism of cells shifts to the solventogenic phase in which organic acids are reassimilated and solvents such as acetone (or isopropanol), butanol and ethanol are produced
Data Source
AI summary
The present invention relates to recombinant microorganisms having an increased ability to produce butanol, and a method of producing butanol using the same. More specifically, the invention relates to recombinant microorganisms whose ability to produce butanol was increased by manipulation of their metabolic networks, and a method of producing butanol using the same. The recombinant microorganisms having an increased ability to produce butanol comprise a deletion of a gene, which encodes an enzyme that converts acetyl CoA to acetate, in host microorganisms having genes that encode enzymes involved in acetyl CoA and butyryl CoA biosynthetic pathway. The recombinant microorganisms obtained by manipulating the metabolic flux of microorganisms are able to selectively produce butanol with high efficiency, and thus are useful as microorganisms for producing industrial solvents and transportation fuels.